EFFICACY OF PIRIBEDIL AT DIFFERENT STAGES OF PARKINSON’S DISEASE

Download full text PDF
Issue: 
3
Year: 
2016

O. Troshina, Candidate of Medical Sciences; T. Esina; A. Chernyshova Voronezh Regional Clinical Hospital One

Piribedil reduces the degree of major motor symptoms, including the manifestations of motor fluctuations and drug-induced dyskinesia, as well as postural disorders, in Parkinson’s disease.
Keywords: 
neurology
Parkinson’s disease
dopamine receptor agonists
levodopa
motor fluctuations
drug-induced dyskinesia

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Diagnostika i lechenie ekstrapiramidnyh rasstrojstv. Pod red. V.N.. Shtoka / M., 2000; s. 138.
  2. Levin O.S., Fedorova N.V. Bolezn' Parkinsona. 3-e izd. / M.: MEDpress . inform, 2012; 352 s.
  3. Kadykov A.S., Manvelov L.S. Testy i shkaly v nevrologii: rukovodstvo dlja vrachej / M.: MEDpress-inform, 2015; 224 s.
  4. Fedorova N.V., Chigir' I.P. Bolezn' Parkinsona // Lechaschij vrach. – 2005; 6: 34–40.
  5. Shtok V.N., Fedorova N.V. Lechenie parkinsonizma / M., 1997; 194 s.
  6. Cohen G. Oxygen radicals and Parkinson's disease. Oxygen radicals and tissue injury. Ed. B. Halliwell / Federation of American Societies for Experimental Biology: Bethesda, MD, 1988; 130–5.
  7. Lang A. Are the new dopamine agonists better than the old ones? 67. th International congress of Parkinson's disease and movement disorders Barcelona. Spain, 2000.
  8. Olanow C., Obeso J. Pulsatile stimulation of dopamine receptors and 8. levodopa-induced motor complications in Parkinson's disease: implications for the early use of COMT inhibitors // Neurology. – 2000; 55 (4): 72–7.
  9. Parkers J., Baxter R., Marsden C. et al. Comparative trial benzhexol, 9. amantadine, and levodopa in the treatment of Parkinson's disease // J. Neural. Neurosurg. Psychiatry. – 1974; 37: 422–6.